All patients with SARS-CoV-2, patients with COVID-19, patients with MIS-C, and patients with HLH had significantly higher values of sCD25 and sCD163 than healthy control children (Table 2; Figs. 1 and 2). The gene discussed is CD163; the disease is COVID-19.